PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-08-22

Date Title Company
23-Aug-2022 Chesterford Research Park welcomes ambitious new biotech firm Chesterford Research Park
22-Aug-2022 IoT in Healthcare Market is projected to reaching US$ 952.3 Billion by 2032 MARKITWIRED
22-Aug-2022 Medical Physics Market Key Players : Gilbert Health Physics, Medical Physics Services, Medical Physics Services Consultants, Inc. MARKITWIRED
22-Aug-2022 3D Cell Culture Market to attain a valuation of US$ 2.67 Billion by 2031 MARKITWIRED
22-Aug-2022 Viscosupplementation Market to reach a valuation of US$ 2.89 Billion by 2030 MARKITWIRED
22-Aug-2022 Platelet Rich Plasma Market is projected to expand at a steady 6% CAGR through 2031 MARKITWIRED
22-Aug-2022 Kaempferol Market is anticipated to be valued at US$ 5.79 billion by 2032 MARKITWIRED
22-Aug-2022 Brain Imaging And Neuroimaging Market is expected to be worth US$ 13,166.5 Million by 2022 MARKITWIRED
22-Aug-2022 Humeral Implants Market is likely to be valued at US$ 963.8 Million in 2022 MARKITWIRED
22-Aug-2022 Humanized Mouse Model Market is expected to be valued at US$ 92.5 Million in 2022 MARKITWIRED
22-Aug-2022 European Medicines Agency Accepts Rezafungin Marketing Authorisation Application for the Treatment of Invasive Candidiasis Mundipharma
22-Aug-2022 Automated CPR Devices Market is expected to grow at approximately 13% CAGR throughout the forecast period by 2031 MARKITWIRED
22-Aug-2022 Keloid Treatment Market is likely to record a CAGR of 8.75% during forecast period by 2032 MARKITWIRED
22-Aug-2022 Non-Surgical Fat Reduction Market is predicted to grow at 16.1% CAGR through 2032 MARKITWIRED
22-Aug-2022 Hips & Knees Reconstructive Market is predicted to grow at 6.4% CAGR during forecast period by 2032 MARKITWIRED
22-Aug-2022 DNA Polymerase Market to exhibit a CAGR of approximately 6.5% during the forecast period by 2031 MARKITWIRED
22-Aug-2022 SMART Advances in the Detection and Quantification of Viral Pathogens in Wastewater SMART
22-Aug-2022 Kinarus Therapeutics to hold webinar on a new approach to treating COVID-19 Kinarus Therapeutics Holding AG
22-Aug-2022 Kinarus announces the issuance of convertible notes of up to CHF 20 million to an entity managed by Yorkville Kinarus Therapeutics Holding AG
22-Aug-2022 Intron Health initiates research coverage of Xlife Sciences Xlife Sciences AG